We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best ...

The list for the next round of medicines that will ... reckons a chronic obstructive pulmonary disease (COPD) drug will be included – and is preparing to contribute to the process.

The Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...

GSK was able to persuade NICE to change its mind after it provided further analyses on its use, as well as an additional price reduction. The drug’s list price is £840 per dose, but the price ...

The deal kicks off with GSK paying South Korea-based ABL £38.5 million (about $49.1 million) up front. The drug delivery approach of ABL is based on Grabody, a platform technology that develops ...

The increased usage of specialty drugs is contributing to the continued ... includes pharmaceutical products. GSK plc (NYSE:GSK) tops our list for being one of the most undervalued stocks.

The company's innovative new product lineup and expansive list of patent-protected drugs create a wide economic moat, in our opinion. The magnitude of GSK's reach is evidenced by a product ...

April 15 (Reuters) - British pharmaceutical giant GSK (GSK.L), opens new tab has not met required ethical and regulatory standards in the marketing and prescription information for its Omjjara ...

Per GSK, the drug targets a different part of the bacteria than most existing antibiotics, making it effective against resistant strains. Additionally, the risk of bacterial resistance is low ...

At GlaxoSmithKline, we never lose sight of the ... In particular, a platform trial design allows efficient evaluation of a drug in combination with agents with different mechanisms of action ...